Skip to main content

Advertisement

Log in

Neopterin im Serum und Urin zur Differentialdiagnose von Nierenfunktionsstörungen nach Nierentransplantation

Neopterin in serum and urine for the differential diagnosis of renal dysfunction in kidney allograft recipients

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

In a period of 10 months neopterin in serum and urine was determined by radioimmunoassay in 33 renal allograft recipients treated with cyclosporin A. While in allograft rejections the highest neopterin concentrations were found in the serum, patients with viral infections after renal transplantation showed the most elevated concentrations in the urine. For early diagnosis of allograft rejection the ratio of neopterin clearance and serum-neopterin was the most significant criterion of the parameters measured in this study. Patients without complications during the follow-up showed slightly elevated and stable neopterin levels in serum and urine. The presented results indicate that neopterin is a useful parameter for the follow-up after renal allograft transplantation and for the diagnosis of immunological complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CyA:

Cyclosporin A

Kr-Cl:

Kreatinin-Clearance

NPT-Cl:

Neopterin-Clearance

sKr:

Kreatinin im Serum

sNPT:

Neopterin im Serum

uNPT:

Neopterin im Urin

Literatur

  1. Bichler A, Fuchs D, Hausen A, Hetzel H, König K, Wachter H (1982) Urinary neopterine-excretion in patient with genital cancer. Clin Biochem 15 (1):38–40

    Google Scholar 

  2. Bichler A, hetzel H, marth Ch, Fuchs D, Hausen A, Reibnegger G, Wachter H (1982) Significance of urinary neopterin in gynecology and obstetrics: oncology, pregnancy, amniotic fluid. Biochemical and Clinical Aspects of Pteridines, Vol. 1, 141–156

  3. Dhondt JL, Hayte JM, Noel C (1985) Pteridines in urine and serum in kidney allograft recipients. Biochemical and Clinical Aspects of Pteridines. Vol 4, pp 419–428

  4. Duncan DB (1955) Multiple Range and multiple F-Tests. Biometrics 11:1–42

    Google Scholar 

  5. Duncan DB (1970) Multiple comparison methods for comparing regression coefficient. Biometrics 26:141–143

    Google Scholar 

  6. Fuchs D, Hausen A, Huber C, Margreiter R, Reibnegger G, Spielberger M, Wachter H (1982) Pteridinausscheidung als Marker für alloantigen-induzierte Lymphozytenproliferation. Hoppe-Seyler's Z Physiol Chem 363 (6):661–664

    Google Scholar 

  7. Fuchs D, Hausen A, Reibnegger G, Wachter H, Huber C et al. (1983) Assessment of urinary neopterin in the early diagnosis of human allograft rejection. Chemistry and Biology of Pteridines, pp 885–890

  8. Hausen A, Fuchs D, Grünewald K, Huber H, König K, Wachter H (1981) Urinary neopterine as marker for haematological neoplasias. Clin Chim Acta 117 (3):297–305

    Google Scholar 

  9. Hausen A, Fuchs D, Grünewald K, Huber H, König K, Wachter H (1982) Urinary neopterine in the assessment of lymphoid and myelid neoplasia, and neopterine levels in haemolytic anaemia and benign monoclonal gammopathy. Clin Biochem 15 (1):34–37

    Google Scholar 

  10. Huber C, Bachtelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, Reibnegger G, Swetly P, Troppmair J, Wachter H (1984) Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma J Exp Med 160:310–316

    Google Scholar 

  11. Huber C, Fuchs D, Hausen A, Margreiter R, Reibnegger G, Spielberger M, Wachter H (1983) Pteridines as a new marker to detect human T cells activated by allogeneic or modified self major histocompatibility complex (MHC) determinants. J Immunol 130 (3):1047–50

    Google Scholar 

  12. Huber C, Fuchs D, Niederwieser D, Hausen A et al. (1984) Neopterin, ein neuer biochemischer Marker zur klinischen Erfassung zellulärer Immunreaktionen. Klin Wochenschr 62:103–113

    Google Scholar 

  13. Kahls P, Fischer M, Dudczak R, Hinterberger W, Lechner K, Schwarzinger I, Frischauf H, Deutsch E, Volc-Platzer B (1985) Radioimmunological determination of serum neopterin in patients following bone marrow transplantation — first results. Biochemical and Clinical Aspects of Pteridines, Vol. 4, pp 411–417

  14. Kern P, Rokos H, Dietrich M (1984) Raised serum neopterin levels and imbalances of T-lymphocyte subsets in viral diseases, acquired immune deficiency and related lymphadenopathy syndroms. Biomed Pharmacoth 38:407–411

    Google Scholar 

  15. Klintmalm GBG, Iwatsuki S, Starzl TE (1981) Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet 1:461–471

    Google Scholar 

  16. König P, Margreiter R, Huber C, Fuchs D, Hausen A, Reibnegger G, Wachter H (1985) Neopterin levels in long-term renal allograft recipients. Immunobiology 169 (2):208–212

    Google Scholar 

  17. Margreiter R, Fuchs D, Hausen A, Huber C, Reibnegger G, Spielberger M, Wachter H (1983) Neopterin as a new biochemical marker for diagnosis of allograft rejection. Transpl 36 (6):650–653

    Google Scholar 

  18. Niederwieser D, Huber C, Gratwohl A, Bannert P, Fuchs D, Hausen A, Reibnegger G, Speck B, Wachter H (1984) Neopterin as a new biochemical marker in the clinical monitoring of bone marrow transplant recipients. Transpl 38 (5):497–500

    Google Scholar 

  19. Niederwieser D, Huber C, Wachter H (1983) Neopterin, ein neuer biochemischer Marker zur Erfassung aktivierter T-Lymphozyten: Wien. Klin Wochenschr 95(5):161–164

    Google Scholar 

  20. Reibnegger G, Fuchs D, Hausen A, Wachter H, Bichler A, Hetzel H, Grünewald L, Huber H (1983) Behavior of neopterin levels in patients with haematological and gynaecological neoplasms. Chemistry and Biology of Pteridines, pp 891–896

  21. Rokos H, Bienhaus G, Gadow A, Rokos K (1985) Determination of neopterin and reduced neopterins by radioimmunoassay. Biochemical and Clinical Aspects of Pteridines. Vol. 4, pp 73–84

  22. Rokos H, Rokos K (1983) A radioimmunoassay for determination of D-erythro-neopterin. Chemistry and Biology of Pteridines, pp 815–819

  23. Rokos K, Rokos H, Frisius H (1982) Pteridines as tumor markers? Attempt of evaluation by HPLC and a radioimmunoassay for neopterin. Biochemical and Clinical Aspects of Pteridines, Vol 1, pp 117–130

  24. Rokos K, Rokos H, Frisius H, Hüfner M (1983) Pteridines in cancer and other diseases. Chemistry and Biology of Pteridines, pp 153–157

  25. Rokos H, Rokos K, Kern P, Dietrich M (1984) Radioimmunoassay for neopterin in serum. Levels in patients with viralinfection, lymphadenopathy syndrome, AIDS, leprosy and in normals after hepatitis vaccination. Biochemical and Clinical Aspects of Pteridines, Vol. 3, pp 503–513

  26. Wachter H, Hausen A, Grassmayr K (1979) Erhöhte Ausscheidung von Neopterin im Harn von Patienten mit malignen Tumoren und Viruserkrankungen. Hoppe-Seyler's Z Physiol Chem 360:1957–1960

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wolf, J., Musch, E., Neuss, H. et al. Neopterin im Serum und Urin zur Differentialdiagnose von Nierenfunktionsstörungen nach Nierentransplantation. Klin Wochenschr 65, 225–231 (1987). https://doi.org/10.1007/BF01715851

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01715851

Key words

Navigation